Fundz

Jasper Therapeutics reported raising $132 Million in an initial SEC Form D filing, from an offering of $132 Million

PUBLIC · JSPRAug 05, 2026

Amount Raised

$132 Million

$132 Million sold, per SEC Form D (first sale Jul 21, 2026)

Round Type

Venture

Redwood CityBiotechnologyHealth CareTherapeutics

Investors

Ikarian CapitalAffinity Asset Advisors

Who to call at Jasper Therapeutics, and when

A new round usually means Jasper Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Jasper Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Jasper Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Jasper Therapeutics

Location

Redwood City, California, United States

About

Our mission is to make safer and potentially curative therapy possible for more patients in need. We are bringing together a team of biotech veterans, leading academic institutions and a strong syndicate of healthcare-focused investors to achieve our vision of developing new therapies for diseases of mast and stem cells, safer and more effective conditioning for monogenetic diseases and new engineered stem cell therapies. Briquilimab (formerly JSP191) is a targeted anti c-Kit monoclonal antibody designed to deplete diseased mast and stem cells as well as enable safer and more effective curative hematopoietic stem cell transplants and stem cell gene therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Jasper Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsMark, Vice President of IT and Facilities at… hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Jasper Therapeutics's next move

See what Strategic adds

Jasper Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.